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ABSTRACT: Gelatin−hyaluronic acid (Gel−HA) hybrid
hydrogels have been proposed as matrices for tissue
engineering because of their ability to mimic the architecture
of the extracellular matrix. Our aim was to explore whether
tyramine conjugates of Gel and HA, producing injectable
hydrogels, are able to induce a particular phenotype of
encapsulated human mesenchymal stem cells without the need
for growth factors. While pure Gel allowed good cell adhesion
without remarkable diﬀerentiation and pure HA triggered
chondrogenic diﬀerentiation without cell spreading, the
hybrids, especially those rich in HA, promoted chondrogenic diﬀerentiation as well as cell proliferation and adhesion. Secretion
of chondrogenic markers such as aggrecan, SOX-9, collagen type II, and glycosaminoglycans was observed, whereas osteogenic,
myogenic, and adipogenic markers (RUNX2, sarcomeric myosin, and lipoproteinlipase, respectively) were not present after 2
weeks in the growth medium. The most promising matrix for chondrogenesis seems to be a mixture containing 70% HA and 30%
Gel as it is the material with the best mechanical properties from all compositions tested here, and at the same time, it provides
an environment suitable for balanced cell adhesion and chondrogenic diﬀerentiation. Thus, it represents a system that has a high
potential to be used as the injectable material for cartilage regeneration therapies.
1. INTRODUCTION
Many tissues in the human body are not able to properly repair
themselves or can only repair small injuries, as in the case, for
example, of skin,1 heart,2 and cartilage.3 Tissue engineering
looks for solutions to these problems by using materials or
scaﬀolds as supports for the formation of new tissue. Before
transplantation, these scaﬀolds can either be seeded with
diﬀerentiated or undiﬀerentiated cells or be acellular if
neighboring cells can migrate to the site of the implant inside
the material. Other factors (e.g., growth factors) or stimuli (e.g.,
mechanical, electrical, or magnetic forces) can be applied to the
scaﬀold-cell system to induce cell diﬀerentiation and promote
tissue repair.4
In this study, we focus on material systems that recapitulate
the properties of soft tissues (e.g., cartilage, muscle, etc.). The
cells in these tissues are within a highly hydrated extracellular
matrix (ECM), which contains glycoproteins (such as collagen,
elastin, and ﬁbronectin) and glycosaminoglycans [GAGs, such
as hyaluronic acid (HA), chondroitin 6-sulfate, and keratan
sulfate], with a composition and topology that is tissue-
speciﬁc.5 For this, we synthesized injectable hydrogels by
combining diﬀerent proportions of gelatin (Gel) and HA,
which are able to enzymatically cross-link. Gel is obtained by
denaturation of collagen and has accessible functional groups
that can react with other molecules. It contains the RGD
sequence, which allows integrin-mediated adhesion.6 HA is
characterized by its high hydrophilicity, good lubrication
capacity due to its high water sorption and retention, good
biocompatibility, and low cell and protein adhesive properties.7
Diﬀerent options have been studied for the cross-linking or
functionalization of HA and Gel hydrogels by forming covalent
bonds. These can be classiﬁed into three groups: chemical,
photochemical, or enzymatic cross-linking.8−11 Both chemical
and photochemical cross-linking can produce inﬂammation and
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cell death, and their surgical procedure is more invasive than
that required for enzymatic cross-linking,12,13 which allows in
situ hydrogel formation; the precursor solutions can be injected
directly into the defect, where the enzyme starts cross-linking
without causing any cytotoxic eﬀects.14
Previous studies combining Gel and HA have demonstrated
their noncytotoxicity and potential for cell adhesion and
spreading.7,15,16 Chen et al. embedded nucleus pulposus (NP)
cells in chemically cross-linked Gel−HA hydrogels for 1 week,
and their results showed good cell proliferation and cell
synthesis of collagen type II, aggrecan, and Sry-type high
mobility group box transcription factor 9 (SOX-9) (chondro-
genic markers), biglycan and decorin (proteoglycans for ECM
integrity), and hypoxia-inducing factor-1 (marker of NP
cells).16 Camci-Unal et al. cultured human umbilical cord
vein endothelial cells in methacrylated mixtures of Gel−HA,
obtaining diﬀerent cellular responses by changing the
concentration of each component.17 These two references are
examples of injectable materials (see also refs 18 and 19), which
intend to mimic the composition of the natural ECM by mixing
Gel and HA in diﬀerent proportions. The most explored
application of these systems has been in articular cartilage, likely
due to the potential of HA to support chondrogenesis.20
However, none of these studies explored the application of
these Gel−HA systems to trigger mesenchymal stem cell
(MSC) diﬀerentiation. Rather, they revealed that encapsulated
chondrocytes kept their phenotype within the gels but only in
media containing chondrogenic growth factors, such as TGF-
β3.16,19 Other similar systems (collagen type II-HA or HA−
Gel), which are based on noninjectable chemistries, have been
used to investigate MSC diﬀerentiation in combination with
chondrogenic growth factors.11,21 Only a few reports focused
on the intrinsic chondrogenic potential of the matrices in the
absence of growth factors, as was the case with the collagen
type II-HA scaﬀolds reported by Murphy et al.22 or the cartilage
decellularized ECM investigated by Burnsed et al.23 However,
these are noninjectable preformed scaﬀolds obtained by
lyophilization or solvent casting of aqueous solutions of
macromolecules, followed by cross-linking.11,21,22 This initial
drying not only generates some porosity but also triggers the
organization of the macromolecules in a way that is very
diﬀerent from the one obtained in injectable hydrogels and
which is kept after the addition of the cross-linker. Equilibrium
water content (EWC), mechanical properties, and the way the
cells interact with these hydrogels are very diﬀerent from those
of injectable hydrogels.24 Therefore, the results obtained on
MSC diﬀerentiation in noninjectable hydrogels cannot be
extrapolated to injectable hydrogels.
Encouraged by the positive results obtained in our previous
work in enzymatically cross-linked Gel−HA hydrogels on
myoblast diﬀerentiation,25 in this work, we evaluate the
inﬂuence of hydrogel composition (proportion of Gel and
HA) on the diﬀerentiation of human MSCs (hMSCs) in the
absence of growth factors. To the best of our knowledge, this is
the ﬁrst time that injectable Gel−HA hydrogels have been
investigated as matrices for MSC diﬀerentiation without the
addition of exogenous factors. The hydrogels are ﬁrstly
physically characterized (rheology, swelling, and in vitro
degradation), and their diﬀerentiation potential is then studied
with encapsulated hMSCs. We assess whether the combination
of both materials leads to an environment that promotes cell
diﬀerentiation more eﬃciently than pure components in a
growth medium (GM), that is, absence of speciﬁc complements
such as growth factors.
Figure 1. Enzymatic reaction of Gel−tyramine and HA−tyramine grafted composites by HRP and H2O2. When both the tyramine conjugates are
mixed, random cross-linking reactions between Gel chains, HA chains, or Gel−HA chains are produced.
ACS Omega Article
DOI: 10.1021/acsomega.7b01303
ACS Omega 2017, 2, 7609−7620
7610
2. RESULTS
Tyramine conjugates of Gel and HA form hydrogels by the
covalent bond of the phenol groups of tyramine when
horseradish peroxidase (HRP) and hydrogen peroxide
(H2O2) are added.
27 When both the conjugates are mixed,
hydrogels with diﬀerent amounts of Gel and HA are obtained
by the random reaction of Gel−HA, HA−HA, or Gel−Gel
chains, as illustrated in Figure 1. Gelation times range from 2 to
4.5 min, with an increase in the gelation time with the increase
in the HA content.25 Gelation time in tyramine conjugates and
other similar injectable hydrogels is usually not aﬀected by the
incorporation of cells,28 and we did not observe any signiﬁcant
change in the presence of cells. However, to ensure complete
cross-linking of the hydrogels in the cell culture experiments,
they were kept for 30 minutes at 37 °C before the addition of
the culture medium. Successful tyramine grafting, tyramine
substitution degree, and mean molecular weight of the tyramine
conjugates of Gel and HA were determined by proton nuclear
magnetic resonance spectroscopy, ultraviolet spectroscopy, and
size exclusion chromatography, and the details can be found in
our previous publications.25,29
2.1. Mechanical Properties. The shear modulus of the
already cross-linked samples was measured. First, a strain sweep
measurement was carried out to obtain the hydrogel linear
viscoelastic range.30 No noticeable change was observed in |G*|
with the strain amplitude throughout the whole amplitude
strain range swept (0.01−15%) in any of the gels (Figure S1).
As can be seen, |G*| increases with the HA ratio, which has
been reported previously in similar systems.18 As a trade-oﬀ
between linearity and noise, subsequent dynamic frequency
sweep tests were performed for 1% strain. The dependence of
G′ and G″ on the frequency for the hybrid gels has been plotted
in Figures 2A and 2B, respectively. The storage modulus is the
dominant contribution to |G*| because G′ ≫ G″ in all gels, as
has also been reported in thiolated Gel−HA hydrogels18 and in
oxidized HA−Gel−adipic acid dihydrazide hydrogels.16 No
signiﬁcant dependence of G′ on the frequency is observed for
the experimental range of frequency swept. Again, the higher
the ratio of HA in the hybrid gel the higher the storage
modulus. No noticeable change was found in the loss modulus
(with a value around 1 Pa, regardless of the gel composition)
until 2−3 Hz, but it did increase at higher frequencies.
The value of G′ at 1 Hz appeared in the range of several
hundreds of Pa and increased with the percentage of HA from
172 to 789 Pa for pure Gel and HA, respectively (Table 1).
Although the rheological properties of hydrogels were
determined in the absence of cells, no changes in the shear
storage moduli are expected when cells are incorporated. This
was demonstrated by Kolesky et al.31 using ﬁbroblasts in
methacrylated Gel and by Moshayedi et al.32 using neural
progenitor cells in methacrylated HA. As far as the loss factor is
concerned, an extremely low value (about 0.1°) was found for
all hybrid gels, indicating a highly elastic energy storing capacity
(Table 1).
2.2. Enzymatic Degradation of Gel−HA Hydrogels.
The degradation of Gel−HA hydrogels was studied by
enzymatic degradation with a 10 U/mL solution of
Figure 2. Rheological properties of Gel−HA hydrogels: (A) evolution of the storage (G′) and (B) loss moduli (G″) as a function of the frequency of
cross-linked hydrogels (1% strain). All measurements were carried out at 37 °C. Each curve corresponds to the average of three diﬀerent samples.
Enzymatic degradation study with 10 U/mL of hyaluronidase and 3 U/mL of collagenase: (C) percentage of mass lost with time for each Gel−HA
hydrogel and (D) EWC of the Gel−HA hydrogels just after synthesis (initial) and after 20−30% of degradation of the matrix (20−30%). Legend in
(B) is also valid for (A,C).
Table 1. Mechanical Properties of Hydrogels Determined by
Rheometrya
Gel−HA hydrogel G′ (Pa) G″ (Pa) δ (deg)
100/0 172 ± 38 0.9 ± 0.3 ∼0.3
70/30 277 ± 32 0.5 ± 0.1 ∼0.1
50/50 366 ± 28 0.5 ± 0.1 ∼0.1
30/70 690 ± 85 1.5 ± 0.3 ∼0.1
0/100 789 ± 220 1.0 ± 0.1 ∼0.1
aStorage (G′) and loss (G″) moduli and phase angle (δ) evaluated at a
frequency of 1 Hz, using 1% strain and at 37 °C for hybrids with
diﬀerent compositions.
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hyaluronidase and 3 U/mL of collagenase in Dulbecco’s
phosphate-buﬀered saline (DPBS), these concentrations being
within the range typically used before.11,17,33,34 A mixture of
both the enzymes was used to reproduce a more relevant
physiological environment than just using a single enzyme.7
Degradation kinetics was studied as the mass lost with time of
immersion in the degradation solution (see Figure 2C). The
Gel hydrogel degraded very rapidly; after 7 h, there was no
hydrogel left, whereas a longer time (5 days) was needed for
HA. This trend has previously been reported by other authors.7
Gel−HA hybrids needed intermediate times to degrade. 70/30
and 50/50 Gel−HA hydrogels showed a degradation proﬁle
similar to the Gel hydrogel, and 30/70 fully degraded after 28 h.
These revealed an important role of Gel in accelerating
degradation (even with only 30% of Gel in the gel) in
comparison to pure HA. A reason for this could be that in
hybrid gels, Gel is ﬁrst degraded by collagenase, leaving spaces
between some of the HA chains that improve the accessibility
for hyaluronidase to degrade this component faster than in the
bare HA hydrogel (0/100).
To better understand how degradation inﬂuences the
hydrogel structure, the EWC of diﬀerent hydrogels at 20−
30% degradation was compared with the EWC of hydrogels
with no degradation (Figure 2D, Table 2). Initial hydrogel
swelling showed an increased water uptake with the higher HA
content. This higher swelling is usually related to the lower
cross-linking density of the polymeric network and chemical
characteristics of the polymeric structure.6,7 EWC is increased
in all compositions studied after degradation, except in the case
of pure HA.
2.3. hMSCs Proliferation. Cells encapsulated within the
hydrogels were viable during the time of the experiment, as
demonstrated by the LIVE/DEAD assay on day 14 (Figure S2
of the Supporting Information). Cell morphology was
monitored during the cell culture experiment on days 2, 7,
and 14 under the microscope. Figure 3 represents gels with
embedded cells after 2 weeks in both culture media [GM and
chondrogenic medium (CM)]; the details for the entire
experiment (2, 7, and 14 days) are shown in the Supporting
Information (Figures S3.1 and S3.2). In the Gel hydrogel, the
cells adhered and showed an elongated morphology in both
culture media (GM and CM) from day 2 (Figures S3.1 and
S3.2). In the case of HA and Gel−HA mixtures, the cells
remained rounded on day 2 after seeding (Figures S3.1 and
S3.2). In the GM, 70/30 and 50/50 hybrids started to show
elongated and better attached cells on day 7 (Figure S3.1),
whereas 30/70 hydrogel facilitated cell-spreading later on as
some elongated cells were observed on day 14 (Figures 3 and
S3.1). In the CM, some cell elongation could be seen after 7
days of culture in Gel−HA hybrids (Figure S3.2). The pure HA
hydrogel did not allow good cell attachment and spreading in
any of the cell culture media, and the cells remained rounded
during the entire experiment (Figures S3.1 and S3.2).
3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS) assay (Figure 4)
demonstrated that the cells did not proliferate in Gel in any
of the culture media (GM and CM). However, a signiﬁcant
proliferation was measured for the hybrid gels in the GM
(Figure 4A). In the case of pure HA, no proliferation was
observed in the GM, and the number of cells diminished with
the culture time, probably due to cell migration out of the
hydrogel because of poor cell adhesion (Figure 4A). The
presence of proliferating cells in the Gel−HA mixtures together
with the results of the LIVE/DEAD assay showing a
homogenous distribution of viable cells across the gel volume
on day 14 (Figure S2) suggest that there was no signiﬁcant
limitation in the nutrient supply, even to the central part of the
gels.
As expected, proliferation was suppressed in all hydrogels in
the CM (Figure 4B), and the number of cells slightly decreased
Table 2. Initial EWC and Cross-Linking Density (ρx) of the
Hydrogels and Values after 20−30% of Hydrogel
Degradation (EWCdeg), (ρx,deg)
Gel−HA
hydrogel EWC [%] EWCdeg [%]
ρx
[mol/m3]
ρx,deg
[mol/m3]
100/0 2924 ± 169 4908 ± 542 1.95 0.68
70/30 4597 ± 489 6833 ± 770 1.14 0.54
50/50 5232 ± 620 10 228 ± 1398 1.11 0.33
30/70 6390 ± 439 10 615 ± 1096 0.93 0.38
0/100 8790 ± 1363 7046 ± 1812 0.69 1.02
Figure 3. Phase contrast images of Gel−HA hydrogels with hMSCs
cultured in GM and CM for 14 days. The scale bar is 100 μm.
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with the culture time for those hydrogels rich in HA (50/50,
30/70, and 0/100).
2.4. hMSCs Diﬀerentiation. hMSCs were encapsulated in
the hydrogels to determine whether spontaneous diﬀerentiation
toward speciﬁc lineages (myogenic, adipogenic, osteogenic, and
chondrogenic) can occur in the absence of a diﬀerentiation
medium.
Immunoﬂuorescence images after 14 days of culture for the
adipogenic marker lipoproteinlipase (LPL), osteogenic marker
RUNX2, and myogenic marker MF20 in Figure 5 suggest that
no diﬀerentiation toward these cell lineages could be seen in
the GM in any of the Gel−HA hydrogels.
Aggrecan was studied as a well-accepted marker for
chondrogenic diﬀerentiation. Aggrecan ﬂuorescence staining
was performed for all Gel−HA compositions both in the GM
(Figure 6) and CM (Figure S4.1) after 14 days of culture.
MSCs cultured in Gel showed a negligible expression of
aggrecan, whereas the presence of HA stimulates the expression
of this marker for all compositions.35
As the hydrogel mixtures and HA seemed to promote
chondrogenic phenotype, other chondrogenic markers were
analyzed to further study these hydrogels: SOX-9 and alcian
blue staining and gene expression for collagen type II in the
GM and CM.
Figure 6 shows SOX-9 for cells cultured in all Gel−HA
compositions in the GM (those in the CM are represented in
Figure S4.2), conﬁrming the positive results of aggrecan
staining.
Alcian blue histologies are depicted in Figure 7, where
glycosaminoglycans (GAGs) are stained in blue, cells are
stained in red, and the background is pink or becomes purple
when the quantity of HA is increased (background of the
diﬀerent hydrogel compositions without cells can be seen in the
ﬁgure as the acellular control). As expected, dark blue staining
of cells in the CM shows the presence of GAGs in all hydrogels.
In the Gel hydrogel, the blue color appears less dark and more
spread than in the other gels, which could be caused by better
cell adhesion associated with a higher Gel degradation rate that
increases the cells’ capacity to synthesize the ECM (including
GAGs) into larger areas. For the cells cultured in the GM,
images obtained for the Gel hydrogel did not contain any blue,
indicating that no GAGs were synthesized under this condition.
In the case of Gel−HA and pure HA, blue areas were observed
around the cells (white arrows in Figure 7), conﬁrming the
presence of GAGs in these gels.
Expression of collagen type II encoded by COL2A1 gene
determined by quantitative polymerase chain reaction (qPCR)
is shown in Figure 8A. The results are represented as a fold
change in the expression relative to pure Gel gels in the GM, to
which a value of 1 was assigned in the graph. In the GM, the
cells within those hydrogels rich in HA, 30/70, and pure HA
express a signiﬁcantly higher amount of collagen type II than
Gel in the GM. The same occurs in the CM, where the
Figure 4. Cell proliferation in Gel−HA hydrogels measured by the MTS assay in the GM (A) and CM (B). The samples were compared by one-way
analysis of variance (ANOVA), and statistical diﬀerences at p < 0.05 are denoted by *, both in each Gel−HA proportion at the diﬀerent time points
and among the diﬀerent Gel−HA compositions at the same time point.
Figure 5. Immunoﬂuorescence images for LPL, RUNX2, and MF20 of
hMSCs cultured in Gel−HA hydrogels and in the GM for 14 days.
Nuclei are stained with 4′,6-diamidino-2-phenylindole (DAPI),
cytoskeleton is stained in green, and the diﬀerent antibodies are
stained in red. The scale bar is 50 μm.
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expression is signiﬁcantly higher compared to the GM for
almost all samples, except for the 70/30 sample.
To quantify the levels of other chondrogenic markers already
observed, immunoﬂuorescence images as well as histological
stainings were further processed to calculate the percentage of
cells expressing aggrecan, SOX-9, and GAGs; the resulting
graphs are shown in Figure 8.
Regarding the percentage of aggrecan expression (Figure
8B), again the presence of higher amounts of HA in the
hydrogel composition increases the percentage of cells
expressing aggrecan. In both CM and GM cultures, statistically
signiﬁcant diﬀerences were obtained between all groups, except
between the 50/50 and 30/70 Gel−HA samples. The highest
percentage of diﬀerentiation was obtained for pure HA
hydrogel (0/100) cultured in the GM, with 79%. This value
was higher than that obtained for the 0/100 sample cultured in
the CM (24%), although the number of cells in this hydrogel is
quite low compared with all other hydrogel compositions. Gel−
HA 50/50 and 30/70 hybrids present similar percentages of
aggrecan diﬀerentiation with 56% for the CM culture and 31%
for the GM culture.
Aggrecan immunoﬂuorescence images were also used to
calculate the number of cells per area (Figure S5A), which gives
us an idea of cell distribution within the diﬀerent hydrogels.
The number of cells per area was seen to increase with the
quantity of Gel in the hydrogel, although there is a marked
drop in the number of cells when HA is present in the hydrogel
composition. Comparing 100/0 and 70/30 hydrogels, there is a
decrease of 66% for cells in the GM and 76% for cells in the
CM. No signiﬁcant statistical diﬀerences were obtained
between the 70/30 and 50/50 hydrogels in either CM or
GM or between the 50/50 and 30/70 hydrogels cultured in the
GM.
As regards the percentage of SOX-9 (Figure 8C) in the CM,
more than 75% of the cells are positive in all Gel−HA mixtures
and HA (with no signiﬁcant diﬀerences among the diﬀerent
hydrogels), whereas only 25% of the cells are positive in pure
Gel. The percentage of positive SOX-9 cells in the GM is
always higher than 45% and increases with the amount of HA
in the mixtures, showing statistically signiﬁcant higher values for
those hydrogels rich in HA, 30/70, and HA samples.
The quantitative analysis of the alcian blue staining allowed
us to calculate the percentage of cells expressing GAGs (Figure
8D), which was complemented with the qualitative analysis
determining the dark blue tone or level and the blue area
around the cell (Figure S5B). In the cell−hydrogel system
cultured in the GM, the percentage of cells synthesizing GAGs
increased with the percentage of HA in the hydrogel up to
values of about 80% in the 30/70 mixture and HA gel. No GAG
expression was detected in the case of Gel in the GM. A high
percentage of cells (around 90%) cultured in the ﬁve types of
Gel−HA in the CM synthesized GAGs. In the qualitative
analysis, a smaller and darker area around the cell was obtained
with increased HA content in the GM, indicating a higher
concentration of GAGs around the cell (Figure S5B).
Figure 6. Immunoﬂuorescence images for aggrecan (Agg) and SOX-9
of hMSCs cultured in Gel−HA hydrogels and in the GM for 14 days.
Nuclei are stained with DAPI in blue, cytoskeleton is stained in green
for Agg pictures and in red for SOX-9 pictures, aggrecan is stained in
red, and SOX-9 is stained in green. The scale bar is 50 μm.
Figure 7. Alcian blue histologies with nuclear fast red staining of
hMSCs cultured in Gel−HA hydrogels and in the GM and CM for 14
days with scale bar 50 μm. White arrows indicate cells producing
GAGs for the samples cultured in the GM. Acellular controls show the
alcian blue histologies for the diﬀerent hydrogels without cells; here
the scale bar corresponds to 100 μm.
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3. DISCUSSION
Our study demonstrates that a combination of tyramine
conjugates of Gel with tyramine conjugates of HA produces
injectable hydrogels with an enhanced shear modulus and
hydration and where chondrogenesis of MSCs without the
need for growth factors is stimulated. This is demonstrated by
an increased expression of aggrecan, SOX-9, collagen type II,
and GAGs. The importance of having hydrogels that do not
need the supplement of growth factors in tissue-engineering
applications is multiple. As described in refs 23 and 36,
chondrogenic growth factors can also induce osteogenesis;
therapies based on them are cost ineﬃcient and not clinically
attractive;37 and the release of growth factors from hydrogels is
usually not sustained unless they are chemically modiﬁed.20
Similar analogs of the ECM based on collagen and GAG have
demonstrated that the range of stiﬀness similar to our matrices,
0.5 kPa, was optimal to direct MSCs toward chondrogenic
lineage.22 However, the same compositions with higher
stiﬀness, 1.5 kPa, upregulated the osteogenic expression. Both
cases were tested in the absence of diﬀerentiation supplements.
Having our composites a lower stiﬀness than the one described
as osteogenic could be the cause of the negative RUNX2
expression in our hydrogels. MSCs myogenic induction also
needs a certain mechanical stiﬀness (10 kPa in ref 38) and
usually requires the addition of several speciﬁc growth factors
when MSCs are encapsulated in hydrogels.39 Although
adipogenesis is promoted in softer hydrogels, MSCs in them
usually need to be in very high densities, which could be the
reason our hydrogels did not show LPL expression.40,41
Although pure Gel hydrogels have been proposed for
cartilage tissue engineering, the adhesion of the encapsulated
cells is very strong and tend to have a stretched morphology
with secretion of markers that are not typical of articular
cartilage, such as collagen type I and hypertrophy markers.35
From the mechanical point of view, Gel stiﬀness is too low
(172 Pa of storage shear modulus, Figure 2A) and is not able to
counterbalance the traction forces exerted by cells, resulting in a
dramatic shrinkage during the in vitro culture, as previously
shown in ref 25. These shortcomings and the fast degradation
rate of Gel make the mixtures more attractive materials.
The chondrogenic potential of HA is well-known20 and has
predominated in the hydrogel mixtures that also promoted
chondrogenesis. During cell mitosis and migration, a thin
pericellular layer rich in HA is secreted by cells, which mediates
their detachment from the ECM and promotes cell rounding.42
In cartilage, the chondrocyte CD44 receptor interacts with
secreted HA chains, keeping the cells surrounded by a gel-like
environment that is crucial for maintaining the diﬀerentiated
phenotype.43 However, pure HA hydrogel has some limitations
because of the low or even null cell proliferation and the fact
that secreted ECM tends to remain in the pericellular space and
not distributed within the hydrogel.35 Our results show that
although in HA, a rounded cell morphology with the expression
of chondrogenic markers is obtained in the GM (Figure 6) and
CM (Figures S4.1 and S4.2) (probably due to the interaction of
hMSCs with the HA chains by the CD44 receptor), the
number of cells is very low and decreases with the time of
culture (Figure 3).
The hybrid Gel−HA matrices mimic the composition of the
ECM and combine the cell adhesive chains of Gel (containing
RGD sequences) with HA chains that are more rigid than Gel,
provide stiﬀness, have a lower degradation rate than Gel, and
induce chondrogenesis. The in vitro cultures in the GM show
that the percentage of cells synthesizing aggrecan, SOX-9,
collagen type II, and GAGs increases with the percentage of HA
in the hydrogel. Although pure HA seems to promote the
chondrogenic phenotype, it is not the best matrix for cartilage
tissue engineering as cell adhesion to this material is very poor,
and it also does not promote cell proliferation. 50/50 or 30/70
Figure 8. Quantiﬁcation of the cell cultures of hMSCs encapsulated in the Gel−HA hydrogels and cultured in the GM and CM for 14 days. (A)
Relative collagen type II gene expression from qPCR, represented as a change in the expression relative to Gel in the GM, to which a value of 1 was
assigned in the graph. One-way ANOVA with Tukey post-test was performed to ﬁnd statistical diﬀerences; * for p < 0.05, ** for p < 0.01, and ***
for p < 0.005. (B) Percentage of positive cells for aggrecan. Mann−Whitney−Wilconson test demonstrated that groups within a type of culture
medium show statistically signiﬁcant diﬀerences between each other, except those marked with “ns” (not signiﬁcant). (C) Percentage of positive cells
for SOX-9 obtained from the immunoﬂuorescence images. One-way ANOVA with Tukey post-test was applied for samples cultured in the CM, and
Kruskal−Wallis nonparametric test was applied for samples cultured in the CM. * for p < 0.05, ** for p < 0.01, and *** for p < 0.005. (D)
Percentage of cells expressing GAGs calculated from alcian blue images. Mann−Whitney−Wilconson test demonstrated that groups within a type of
culture medium show statistically signiﬁcant diﬀerences between each other, except those marked with “ns” (not signiﬁcant).
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Gel−HA mixtures seem to be better candidates for the
encapsulation of hMSCs as they allow both cell adhesion and
proliferation and still beneﬁt from the presence of HA,
enhancing cell diﬀerentiation into the chondrogenic phenotype.
Our results are consistent with others reporting that the
incorporation of HA in hydrogels promotes chondrogenic
diﬀerentiation.19,28 In particular, Levett et al.19 demonstrated
that dediﬀerentiated chondrocytes encapsulated in three-
dimensional Gel−HA hydrogels containing small amounts of
HA were able to rediﬀerentiate to chondrocytes.
As Gel resulted in a higher substitution degree of tyramine
than HA,25 Gel network is more cross-linked than HA, which is
consistent with its lower swelling capacity in comparison to HA
(Figure 2D and Table 2), being the mixtures between the
values of pure networks. The apparent cross-linking density was
calculated elsewhere25 and was higher for Gel (1.95 mol/m3)
than for HA (0.69 mol/m3), having the mixtures cross-linking
densities within these values (Table 2). The apparent cross-
linking density of the degraded hydrogels (20−30% mass loss)
decreased for Gel and Gel−HA mixtures, obtaining a decrease
from 1.95 to 0.68 mol/m3 for pure Gel hydrogel (Table 2), as
usually occurs in bulk homogeneous degradation of networks.27
Internal hydrogel degradation creates a chain cleavage in the
peptide bond (for Gel)6 and in the β-1-4 glycosidic linkages
(for HA),27 causing reduced hydrogel cross-linking that creates
loosened networks of higher mesh size with more hydroxyl
groups or bigger pores capable of absorbing more water. Also,
because Gel degrades ﬁrst (Figure 2C), it will leave gaps or
small pores that will increase enzyme diﬀusion and hydrogel
degradation. On the other hand, no change in EWC was
obtained after 30% degradation in the HA hydrogel (Figure
2D). As previously reported,44 the diﬃculty of hyaluronidase
diﬀusion inside the pure HA hydrogel provokes surface
degradation causing hydrogel mass loss without changing the
apparent cross-linking density, which seems to increase from
0.69 to 1.02 mol/m3 after 20−30% degradation (see Table 2)
but with no signiﬁcant diﬀerence from the nondegraded sample
(Figure 2C).
The mechanical stiﬀness of hydrogels depends on the cross-
linking degree, the water content, the chemical composition,
the rigidity of the chains, and the water permeability coeﬃcient.
Because HA has a lower cross-linking degree, it would be
expected that hydrogels with a higher HA content would have a
lower shear modulus. However, this is not the case because
hydrogels with a higher HA content have a higher mechanical
modulus and a higher swelling degree (Figure 2A,D). The
rigidity of HA chains in water and the lower hydraulic
permeability of water from HA would explain an increase in the
storage modulus of the hydrogels from 172 Pa for pure Gel to
789 Pa for pure HA (Figure 2A)21,25 as the ratio of HA in the
mixtures increases.
Overall, the 30/70 Gel−HA mixture shows characteristics
that are most suitable for regenerative therapies in cartilage
damage. It is the composite that had the lowest degradation
rate but still presented bulk degradation demonstrated by the
lower cross-linking density after 20−30% degradation. This
means that those spaces left in the hydrogel mesh after
degradation would allow spreading of secreted ECM, which
would not occur in pure HA where surface degradation was
inferred from the swelling results after degradation. This
mixture still beneﬁts from integrin adhesion cues provided by
Gel that promotes cytoskeleton development and cell
proliferation. In addition, the high HA content allowed to
increase the mechanical stiﬀness up to 690 Pa, very close to that
of pure HA, conﬁrming the stability of the network provided by
HA in the mixtures, and most importantly, it has been the
composite that shows the greatest beneﬁt from the
chondrogenic HA biochemical cues in the absence of
diﬀerentiation supplements. 30/70 Gel−HA hydrogel is the
only mixture that showed a signiﬁcant diﬀerence of collagen
type II expression and SOX-9 positive cell percentage
compared to Gel in the GM. Furthermore, aggrecan and
GAGs positive cell percentage of the 30/70 composite is the
highest among the mixtures and equal to the percentages found
in pure HA. The null proliferative potential, poor cell
cytoskeleton development, and surface degradation proﬁle
could be suﬃcient arguments to defend that the HA hydrogel
needs the combination with small amounts of cell adhesive
protein to optimize its chondrogenic potential, whereas pure
Gel results in insuﬃcient mechanical stiﬀness and enhanced cell
adhesion inhibiting MSC chondrogenesis in three-dimension in
the absence of speciﬁc growth factors.
4. CONCLUSIONS
Enzymatically cross-linked injectable Gel and HA hydrogel
hybrids show a high potential as systems for the regeneration of
articular cartilage as chondrogenic diﬀerentiation is promoted
even in the GM. Including HA in the mixtures provides better
mechanical properties than pure Gel and adds stability in terms
of degradability. Moreover, the presence of HA stimulates
aggrecan, SOX-9, collagen type II, and GAG synthesis. Gel is
needed in the hybrids to improve cell adhesion and for their
retention/proliferation over an extended period as very few
cells are found in the pure HA hydrogels.
5. EXPERIMENTAL SECTION
5.1. Materials. HA sodium salt from Streptococcus equi and
Gel from porcine skin (gel strength 300, type A) were
purchased from Sigma-Aldrich (USA). Sodium chloride
(synthesis grade) and potassium dihydrogen phosphate (extra
pure) were purchased from Scharlab (Spain). N-(3-Dimethy-
laminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) was
supplied by Iris Biotech GmbH (Germany). All other reagents
used in the Gel−HA synthesis and characterization were
purchased from Sigma-Aldrich.
Calcium-free Krebs Ringer buﬀer (CF-KRB) solution was
prepared with 115 mM sodium chloride, 5 mM potassium
chloride, 1 mM potassium dihydrogen phosphate, and 25 mM
4-(2-hydroxyethyl)piperazine-1-ethanesulphonic acid.
For cell culture experiments, the human bone marrow
mesenchymal stem cells (BM-hMSCs) were purchased from a
commercial lineage (PromoCell, Germany). Primary antibodies
against aggrecan (mouse), SOX-9 (mouse), RUNX2 (rabbit),
and LPL (rabbit) were purchased from Santa Cruz
Biotechnologies (USA). Mouse primary antibody for myosin
(MF-20b, 800 μg/mL) was purchased from Developmental
Studies Hybridoma Bank (DSHB, USA). Secondary antibodies
rabbit anti-mouse IgG Cy3 and goat anti-rabbit IgG Cy3 were
purchased from Jackson Immunoresearch (USA), and donkey
anti-mouse AF 488 antibody was purchased from Life
Technologies (UK). Fungizone, insulin-transferrin-selenium-X
(ITS-X), phosphate buﬀered saline (PBS), DPBS were
purchased from Gibco, ThermoFisher Scientiﬁc (USA).
BODIPY phallacidin and rhodamine phalloidin were purchased
from Life Technologies (USA). TGF-β3 was purchased from
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R&D Systems (USA). Embedding medium for cryotomy
(OCT compound) was purchased from VWR (USA).
VECTASHIELD with DAPI was purchased from Vector
Laboratories (USA). DPX mounting medium was purchased
from Fisher Scientiﬁc (USA). Alcian blue 8GX and nuclear fast
red (94%, pure) were purchased from Acros Organics (USA).
RNeasy Micro Kit, QuantiTect Reverse Transcription Kit and
QuantiFast SYBR Green PCR Kit were purchased from Qiagen.
SsoAdvanced PreAmp Supermix was bought from Bio-Rad, and
primers for collagen type II qPCR were ordered from
Invitrogen. All other reagents were purchased from Sigma-
Aldrich.
5.2. Gel and HA Hydrogel Synthesis. Hydrogel mixtures
with diﬀerent proportions of Gel and HA were obtained by
enzymatically cross-linking their tyramine conjugates in the
same way as described in ref 25.
For tyramine grafting onto Gel, 2% (w/v) Gel in 50 mM 2-
(N-morpholino)ethanesulfonic acid (>99%, MES) was dis-
solved at 60 °C under stirring. Then tyramine hydrochloride
(98%, Tyr) was added (2:1 Tyr/COOH molar ratio) and
stirred for 20 min at room temperature (RT). The pH was
adjusted to 6 and N-hydroxysucciniamide (NHS) (98%) was
added and stirred. EDC was then added, and the mixture was
stirred for 24 h at 37 °C. The molar ratios were 2:1 for EDC/
COOH and 1:10 for NHS/EDC. The solution was then
dialyzed [dialysis tubing 12 400 molecular weight cutoﬀ
(MWCO)] against deionized water for 48 h. Finally, the
modiﬁed Gel was lyophilized in a LyoQuest freeze dryer
(Telstar Life Science Solutions, Japan).
Before tyramine bonding with HA, the molecular weight of
HA was reduced from 1.06 MDa to ∼320 000 Da by acidic
degradation.25 For the tyramine grafting, 0.5 w/v % of the low-
molecular-weight HA was dissolved in 150 mM NaCl, 276 mM
MES, and 75 mM NaOH at pH 5.75. Subsequently, tyramine
hydrochloride was added (2:1 Tyr/COOH molar ratio) and
stirred until dissolution, and the pH was adjusted at 5.75.
Afterward, EDC (1:1 EDC/COOH molar ratio) and NHS
(1:10 NHS/EDC molar ratio) were added and stirred for 24 h
until the reaction was completed. Finally, dialysis (dialysis
tubing of 3500 MWCO) against 150 mM NaCl was performed
for 24 h and against deionized water another 24 h, with three
changes of dialysis solution each day. The modiﬁed HA was
dried in the lyophilizer.
To prepare the hydrogels, solutions of pure tyramine-
modiﬁed Gel and HA at 2 w/v % in CF-KRB were made at 37
°C. For proper HA dissolution, the solution was prepared 1 day
early and left to dissolve at 4 °C for 24 h. Gel solution (2 w/v
%) was fully dissolved after 30 min at 37 °C. Diﬀerent
volumetric proportions of Gel−HA were obtained (100/0, 70/
30, 50/50, 30/70, and 0/100). The hydrogels were formed with
80 v/v % of the 2 w/v % Gel−HA mixtures, 10 v/v % HRP at
12.5 U/mL (1.25 U/mL in the ﬁnal volume), and 10 v/v %
H2O2 20 mM (2 mM in the ﬁnal volume) after few minutes of
adding the peroxide.
5.3. Mechanical Characterization of Hydrogels by
Rheology. Shear deformation rheological experiments were
performed on a strain-controlled AR-2000ex rheometer (TA
Instruments). A solvent trap geometry of parallel plates (made
of nonporous stainless steel, diameter = 20 mm) was used to
reduce the solvent loss during the experiment. The gap
between the plates was around 1200 μm. The sample
temperature was controlled and maintained by a Peltier device
at 37 °C. The mixtures of Gel, HA, and the enzyme (HRP)
were arranged on the plate at 37 °C and cross-linked by adding
the correct amount of H2O2. After 20 min, the samples had
been cross-linked, and two diﬀerent measurements were
performed. First, the range of strain amplitudes at which the
gels exhibit a linear region of viscoelasticity was determined. A
dynamic strain sweep (with amplitudes ranging between 0.01%
and 15%) was carried out at a frequency of 1 Hz to measure the
dynamic shear modulus as a function of strain. Second, to
determine the dependence of the dynamic shear modulus and
loss factor on the frequency, a dynamic frequency sweep test
was performed between 0.1 and 10 Hz at 1% strain,
corresponding to the hydrogel linear region.
The following data were obtained from the rheological
measurements: storage modulus (G′), loss modulus (G″),
complex modulus magnitude [|G*|, a measure of the hydrogel
stiﬀness: |G*|2 = (G′)2 + (G″)2], and loss factor [tan δ ≡ (G″)/
(G′), a measure of the internal energy dissipation, where δ is
the phase angle between the applied stimulus and the
corresponding response] as a function of the strain amplitude
or frequency.
5.4. Enzymatic Degradation Study. After the hydrogel
synthesis, the hydrogels were left overnight in DPBS with 0.02
w/v % sodium azide to remove unreacted substances and reach
equilibrium swelling. The in vitro degradation of Gel−HA
hydrogels was subsequently performed by incubating the
hydrogels with hyaluronidase and collagenase at 37 °C.
Cylindrical samples (7 mm diameter and 280 μL volume)
were incubated in 10 U/mL of hyaluronidase (type IV-S from
bovine testes, Sigma-Aldrich) and 3 U/mL of collagenase (type
IA from Clostridium histolyticum, Sigma-Aldrich) solutions in
DPBS with 0.5 w/v % sodium azide at 37 °C. Five replicates
were conducted for each composition and time point.
Degradation was followed by mass loss of the hydrogel as a
function of time. The initial swollen mass (ms,t0) was noted and
measured at diﬀerent time points (ms,t), which provided mass
loss by eq 1
=
−
×
m m
m
% mass loss 100
t t
t
s, s,
s,
0
0 (1)
The EWC of the hydrogel swollen in DPBS with 0.02 w/v %
sodium azide overnight, which was used for comparison after
formation after reaching 20−30% degradation, was obtained by
eq 2
=
−
×
m m
m
% EWC 100s,d d,d
d,d (2)
where ms,d is the swollen mass at 20−30% degradation and md,d
is the dried mass at 20−30% degradation.
5.5. Cell Culture in Gel−HA Hydrogels. BM-hMSCs
were expanded in the presence of a GM consisting of
Dulbecco’s modiﬁed Eagle’s medium (DMEM), a high
glucose-based medium with 0.4% penicillin/streptomycin
solution (stock solution, 10 000 U/mL penicillin and 10 mg/
mL streptomycin), 1 mM L-glutamine, 0.05% FUNGIZONE
(stock solution at 250 μg/mL), 100 μM sodium pyruvate, and
10% fetal bovine serum (FBS) at 37 °C and 5% CO2 in an
incubator.
Gel (2 w/v %) and HA (2 w/v %) solutions were prepared
by dissolving the lyophilized powder in DMEM with 1% P/S,
24 h at 4 °C for HA and 30 min at 37 °C for Gel. HRP solution
(12.5 U/mL) was then added to the prepared solutions at a
volume ratio of 10/80 (mL of HRP/mL Gel or HA solution),
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and the obtained mixture was ﬁltered through a 0.22 μm
syringe ﬁlter for sterilization. Then, solutions in diﬀerent
proportions (100/0, 70/30, 50/50, 30/70, and 0/100 v/v) of
Gel + HRP and HA + HRP were prepared.
BM-hMSCs were detached from the ﬂask using trypsin
ethylenediaminetetraacetic acid, neutralized with the GM,
centrifuged at 1400 rpm for 5 min, resuspended in the GM,
and counted with a hemocytometer. The required amount of
BM-hMSCs (passage 6−7) cells (1 × 106 cells/mL) was added
to each Gel−HA mixture. Finally, 45 μL of the Gel−HA cell
suspension was cross-linked with 5 μL of 20 mM H2O2 on each
well of the cell culture plate and left in an incubator at 37 °C
and 5% CO2 for 30 min to ensure hydrogel cross-linking.
Finally, triplicates of each composition were cultured in the GM
and CM, the latter composed of GM without FBS and with 100
nM dexamethasone, 1% ITS-X, 50 μg/mL ascorbic 2-
phosphate, 40 μg/mL L-proline, and 10 ng/mL TGF-β3.26
The hydrogels formed a drop of about 7 mm diameter at the
bottom of the cell culture wells (nonadhesive wells were used
to prevent cell interaction with them), which means that the
maximum thickness of the hydrogels was 3.5 mm. Cell culture
was followed for 14 days, and the cell medium was changed
every 2 days.
5.6. Cell Proliferation Assay (MTS). Cell proliferation was
studied by analyzing the cell viability on days 2, 7, and 14 of
culture using the MTS assay, following manufacturer
instructions. Brieﬂy, the cell-cultured samples (four replicates)
were moved to a new cell culture plate and incubated with a
fresh culture medium without phenol red or FBS but
containing the MTS reagent (ratio 5:1) at 37 °C for 2 h in
the dark. Thereafter, the absorbance of 100 μL of supernatant
transferred to a new cell culture plate was measured at 490 and
690 nm with an Inﬁnite 200 PRO plate reader (Tecan,
Switzerland). Absorbance at 490 nm is proportional to the
number of viable cells in each sample, whereas the absorbance
at 690 nm is used to subtract the potential background signal of
small pieces of hydrogels inside each well.
5.7. Immunoﬂuorescence Study. After 14 days of culture,
the samples were washed with PBS, ﬁxed with 4% form-
aldehyde for 15 min, and washed again with PBS to remove the
formaldehyde solution. After the ﬁxing step, the samples were
soaked overnight in 30 w/v % sucrose in DPBS, embedded in
OCT, and frozen with liquid nitrogen. Finally, 40 μm sections
were cut out with a Leica CM 1860 UV cryostat.
Gel−HA gel sections cultured in the GM and CM were
immunostained for aggrecan and SOX-9, two characteristic
components of articular cartilage. First, the sections on the
slides were washed and rehydrated with PBS, permeabilized
with 0.1% Triton X-100 in PBS for 20 min at RT and given two
5 min washes with PBS. The blocking buﬀer, formed by 1%
bovine serum albumin (BSA) solution in PBS, was then added
for 1 h at RT, and two washes with PBS were performed.
Primary antibodies were diluted 1:100 in the blocking buﬀer,
and two sets of samples were separately incubated with
aggrecan and SOX-9 antibody solutions for 1 h at RT. Then,
the samples were washed and incubated with donkey anti-rabbit
rhodamine secondary antibody solution for aggrecan staining
and with the donkey antimouse AF 488 secondary antibody for
SOX-9 for 1 h at RT, both secondaries diluted 1:200 in the
blocking buﬀer. Finally, two washes with PBS for 10 min were
carried out; actin was stained with BODIPY FL phallacidin
(aggrecan) or with rhodamine phalloidin (SOX-9) for 30 min
at RT (both diluted 1:100 in PBS). The samples were washed,
and the slides were mounted with VECTASHIELD with DAPI.
For Gel−HA samples cultured in the GM, other antibodies,
characteristic of other cell lineages, were tested to determine
whether the BM-hMSCs in these types of gels tend to
diﬀerentiate into one or the other cell lineage. For this, the
hydrogel sections were washed and rehydrated with PBS,
permeabilized with 0.5% Triton X-100 in PBS at RT, rinsed
with PBS twice for 5 minutes, blocked in 1% BSA/0.1% Triton
X-100 in PBS for 1 h at RT, and rinsed with PBS. The following
primary antibodies were then incubated in the blocking buﬀer
for 1 h at RT: rabbit polyclonal RUNX2, rabbit polyclonal LPL,
and mouse monoclonal MF-20. Two 5 min washes were
performed, and the secondary antibody Cy3 antimouse or
antirabbit was incubated, according to the primary antibody
used, at 1:200 in the blocking buﬀer for 1 h at RT. After two
washes with PBS, actin was stained with BODIPY phallacidin
1:100 in PBS and washed twice for 10 min, and the stained
sections were mounted in VECTASHIELD with DAPI.
5.8. Alcian Blue Histochemistry. Gel−HA hydrogels
without cells, as controls, and samples cultured for 14 days in
the GM or CM were stained with alcian blue to localize GAGs
within the hydrogels. The hydrogel section slides were
rehydrated by washing with PBS twice for 5 min and then
incubated in 1% alcian blue in 0.1 N HCl at pH 1 for 30 min to
stain sulfated GAGs, rinsed with tap water and distilled water,
and counterstained with 0.1% nuclear fast red for 5 min. The
slides with the sections were then rinsed in tap water, rinsed
with distilled water, and dehydrated with increasing ethanol
solutions (70 and 90%) and xylene for 1 min each wash.
Finally, the sections were mounted with the DPX mounting
medium. GAGs positive staining was documented by optical
microscopy using bright-ﬁeld illumination.
5.9. Gene Expression for Collagen Type II. RNA was
extracted from the gels after 14 days of incubation using an
RNeasy Micro kit; brieﬂy, samples were washed with PBS, then
lysed/homogenized, mixed with 70% ethanol, and loaded onto
a microcolumn and spun; then the columns were washed,
DNase treated, washed again, and ﬁnally eluted in sterile water.
After RNA concentration measurement and RNA quality check
on NanoDrop, cDNA was synthetized; preampliﬁcation step
was performed using a ProFlex thermocycler (Applied
Biosciences), and ﬁnally, qPCR was run on a CFX-96
thermocycler (Bio-Rad) using GAPDH as the housekeeping
gene. The primer sequences were as follows: COL2A1-forward
5′-GGC AAT AGC AGG TTC ACG TAC A-3′; COL2A1-
revers 5′-CGA TAA CAG TCT TGC CCC ACT T-3′;
GAPDH-forward 5′-AGG TCG GTG TGA ACG GAT TTG-
3′; GAPDH-revers 5′-TGT AGA CCA TGT AGT TGA GGT
CA-3′. Results were analyzed with CFX Manager software.
5.10. Statistical Analysis. For the statistical studies, either
Statgraphics or GraphPad Prism5 software was used. Mann−
Whitney−Wilcoxon test, one-way ANOVA with Tukey post-
test, Kruskal−Wallis nonparametric test with Dunn’s post-test,
or unpaired two-tailed t-test was performed where applicable.
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